You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data

Article metrics

Article menu
Download PDFPDF
Oral Presentations
Abstract Session PReS: Clinical and basic developments in paediatric rheumatology
OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 20141701
Mar 2014200
Apr 2014800
May 2014300
Jun 2014100
Aug 2014502
Sep 20141600
Oct 2014501
Nov 2014500
Dec 2014700
Jan 2015502
Mar 2015601
Apr 2015500
May 2015601
Jun 2015300
Jul 20151101
Aug 2015700
Sep 2015500
Oct 2015100
Nov 20151101
Dec 2015703
Jan 2016100
Feb 2016100
Mar 2016301
Apr 2016200
May 2016700
Jun 2016100
Jul 20161201
Aug 2016801
Sep 2016300
Oct 2016601
Nov 2016300
Dec 2016400
Jan 2017600
Feb 2017400
Mar 2017500
Apr 2017300
May 2017700
Jun 2017302
Jul 20171001
Aug 2017600
Sep 20171601
Oct 2017200
Nov 2017400
Dec 20171000
Jan 20181600
Feb 2018200
Mar 20181200
Apr 20181400
May 20181600
Jun 2018400
Jul 20181600
Aug 20181400
Sep 2018600
Oct 2018400
Nov 20181000
Dec 2018600
Jan 20191600
Feb 2019400
Mar 2019200
Apr 2019400
May 2019400
Jun 2019400
Nov 2019200
Dec 2019600
Feb 2020200
Mar 2020100
Jul 2020700
Sep 2020800
Nov 2020200
Dec 2020400
Jan 2021600
Feb 2021601
Mar 20211603
Apr 2021200
May 2021600
Jun 2021100
Jul 2021200
Sep 2021100
Oct 2021201
Nov 20211400
Dec 2021900
Jan 2022700
Feb 2022800
Mar 2022500
Apr 2022400
May 2022500
Jun 2022300
Jul 20221600
Aug 2022200
Sep 2022400
Oct 2022600
Nov 2022400
Dec 2022400
Jan 2023800
Feb 2023401
Mar 2023800
Apr 2023200
May 2023400
Jun 2023902
Jul 2023400
Aug 2023200
Sep 2023800
Oct 20231800
Dec 20231200
Mar 2024800
Total669029